Eli Lilly has unveiled plans to close its Singapore R&D centre by the end of the year and relocate discovery operations to its global headquarters in the US.
Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.
A week of global anti-counterfeiting law enforcement coordinated by Interpol led to the shutdown of 290 websites, seizure of 11,000 packages and confiscation of 1m pills.
SGS Life Sciences will roll out new biologics testing capabilities across its network in bid to be the world’s number one contract biopharmaceuticals testing laboratory by 2014.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at AMRI, Novella Clinical, BioClinica and Idis.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including board elections at ISPE and appointments at Advaxis and Asubio.
BioFocus has sealed two compound management deals with the National Cancer Institute and eMolecules, while extending its relationship with Chiesi Farmaceutici for $3.5m (€2.5m).
IMS Health predicts that global drug sales will increase 5 to 7 per cent next year, driven by development of innovative pharmaceuticals and growth of emerging markets.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Aurobindo, DPT, Ricerca and Datatrak.
China leads the field in 'potential future' API suppliers, positioning it to become a dominant force as these companies develop, Thomson Reuters said at CPhI 2010.
GlaxoSmithKline has told its workforce that 55 jobs will be axed at its manufacturing base in Currabinny, Co Cork, and 66 jobs will be lost as a result of revised shift-working plans.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Oso BioPharmaceuticals, Creabilis SA and Clondalkin.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Kendle, INC, AAIPharma and ClinTec.
Quintiles has established a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export, focused on providing pharmaceutical contract sales and promotional services in Egypt.
Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber.
The US FDA and NIH are funding research into bioinformatics-modelling of nanoparticles as part of a collaborative initiative to advance regulatory science.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Velesco, Acurian, Asterand and Cmed.
GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its cancer...
India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.
Worrying times lie ahead for Pfizer’s advertiser, Aegis Group’s Carat, as the drug giant has decided to review its $1.3bn media account, as the firm is speculated to be slashing its outgoings.
The US FDA’s risk evaluation mitigation strategy (REMS) can be a challenge for pharmaceutical companies unfamiliar with the process according to PPD’s executive director of risk management Frank Gallo.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Norgine, CDRD and Prometheus Laboratories.
SOCMA CEO predicts reintroduction of rejected permanent R&D tax credit plan and urges Congress to act “sooner rather than later” to support US manufacturers.
Danish biopharma giant, Novo Nordisk is expanding its R&D Centre in China by introducing a new Diabetes Research unit and doubling its quota of employees from 100 to 200 by 2015.
Forest Pharmaceuticals has pleaded guilty to obstruction of an FDA inspection and agreed to pay $313m (€239m) in criminal and civil penalties to resolve this and other issues.
Addressing the drug industry's need to demonstrate value to stakeholders presents a significant opportunity for service providers, according to Jim Featherstone, VP of Quintiles' commercial arm.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Protalix, Pevion, NeoStem and ProStraken.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at AMRI, Oracle, Cmed, BioClinica and BioStorage.
Global biopharmaceutical company, Bristol-Myers Squibb will buy ZymoGenetics for $885m to become owner of a hepatitis C drug the companies are jointly developing.
DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has announced the launch of InnoSyn route scouting services, meeting pharma needs to outsource process development R&D.
Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, Kendle, Synexus and Gene Logic.
